Skip to content
Home/Blog/Business Tax
Business Tax

R&D Tax Credit US UK: UK R&D Relief vs the US Section 41 Credit for Cross-Border Startups

A UK company with a US-citizen owner or a US subsidiary can look at two research incentives that almost never overlap. How the UK merged scheme and the US Section 41 credit differ, what the 2026 Budget changed, and why where the research happens decides the answer.

Updated:November 17, 2026
Reading Time:12 min read
Brass gears and a small wooden prototype on navy cloth in a bright workshop, for the R&D tax credit US UK comparison
A UK startup building a prototype can look at a UK R&D tax credit while the US research tax credit asks where the work was done.

The R&D tax credit US UK question has a split answer: the UK merged scheme pays a taxable 20% credit on a UK company's qualifying R&D, while the US Section 41 credit rewards research done in the United States and excludes research done abroad. A UK startup with a US-citizen founder or a US subsidiary therefore has to decide where the research happens before it can say which incentive, if either, is in play.

This post is about the interaction, not a re-run of the basics. For how a US citizen taxes a UK company's profit, read our guides on founder tax for a US/UK startup, choosing between a UK and a US entity and GILTI for a small UK company. Here the focus is the research incentive itself. It reflects GOV.UK and IRS guidance checked on 17 November 2026, after the UK Budget of 28 October 2026. It is general information, not advice on a particular claim.

How does UK R&D relief work in 2026?

For accounting periods beginning on or after 1 April 2024, UK R&D relief runs through two schemes that replaced the old SME and RDEC schemes: the merged R&D expenditure credit and enhanced R&D intensive support (ERIS). GOV.UK says the qualifying expenditure rules are identical and the calculation of the credit differs.

The merged scheme: a 20% taxable credit

The merged scheme is open to a company that is trading, chargeable to UK Corporation Tax and carrying out a project that meets the definition of R&D. The rate is 20% of qualifying costs, and GOV.UK describes the credit as liable to Corporation Tax because it is classed as trading income. The credit is first used against the company's Corporation Tax and can then be paid out, subject to the PAYE and National Insurance cap, which GOV.UK sets at £20,000 plus 300% of the company's relevant PAYE and National Insurance liabilities for the period.

ERIS: for loss-making, R&D intensive SMEs

ERIS lets a loss-making SME that meets the intensity condition deduct an extra 86% of its qualifying costs, making 186% in total, and claim a payable credit that is not taxed, worth up to 14.5% of the surrendered loss. The intensity condition asks that relevant R&D expenditure is at least 30% of total expenditure, counting connected companies. That wording matters for a group with a US parent or sister company, because a connected company's spending counts in the test even when it is overseas.

What qualifies, and what the Budget changed

A project must seek an advance in a field of science or technology by resolving scientific or technological uncertainty, and the advance has to be an advance in the overall field, not just for the business. The merged scheme applies whatever the size of the company, and subsidised costs are no longer a restriction for accounting periods beginning on or after 1 April 2024.

The Budget of 28 October 2026 did not touch the headline rates in the GOV.UK guidance checked for this article. Its R&D measure is administrative: companies making claims on or after 1 April 2027 will no longer need to submit the claim notification form, and the additional information form will be simplified from autumn 2027. HMRC's note says the form change goes through the Finance Bill 2026-27, so treat it as announced policy rather than enacted law until that Bill receives Royal Assent.

What does the US Section 41 research credit cover?

The US research credit under Section 41 is claimed on Form 6765. The IRS instructions describe it as a percentage of qualified research expenses over a base amount, with an alternative simplified credit as a second method. The research has to pass the four-part test: it must be undertaken to discover information that is technological in nature, be intended for a new or improved business component, and substantially all of its activities must be elements of a process of experimentation.

The instructions list activities that do not qualify, including research conducted after commercial production begins, duplication of an existing product, certain internal-use software, research funded by another person or a government, and research conducted outside the United States or a US territory. That last exclusion is the one that decides most UK/US cases.

Section 174 and 174A: the 2025 change in plain terms

Public Law 119-21 added Section 174A. For tax years beginning after December 31, 2024, domestic research and experimental expenditures can be deducted, or the taxpayer can elect to capitalise and amortise them over at least 60 months. Foreign research and experimental expenditures stay under Section 174 and are amortised ratably over 15 years, starting from the midpoint of the tax year, as the IRS explains in Rev. Proc. 2025-28. The split between domestic and foreign follows where the research is performed, the same line the Section 41 credit draws.

The payroll tax election for small businesses

A qualified small business, being a corporation or partnership with gross receipts under $5 million for the tax year and no gross receipts before the five-tax-year period ending with that year, can elect to apply up to $500,000 of research credit against the employer portion of social security tax. The instructions say the election is made annually, must be made by the due date of the return including extensions, and cannot be made for a year if it was made for five or more preceding years. For an early-stage US subsidiary with little or no income tax to offset, this is often the only way the credit produces cash.

Does a US citizen who owns a UK company get the US credit for UK research?

No, the owner's citizenship does not move UK research into Section 41. A UK private company is a foreign corporation for US tax. If a US citizen owns it, the company is usually a controlled foreign corporation, and the owner reports it on Form 5471 each year. The company is not itself a US taxpayer filing Form 6765, and even if its profit flows into the owner's US return, the Form 6765 exclusion for research conducted outside the United States still applies to research done in the UK.

The result is lopsided: a UK company can have a UK incentive for UK research, and the US owner can have no US incentive for the same work. Our guide to the check-the-box election for a UK company explains why changing the US classification of the UK company changes how its income is reported, and that does not change where the research is performed for Section 41.

UK vs US R&D incentives side by side

PointUK merged scheme and ERISUS Section 41 credit
Who claimsA trading company chargeable to UK Corporation TaxA US taxpayer with qualified research expenses; Form 6765
Rate or method20% merged credit; ERIS up to 14.5% of surrendered loss plus 186% deductionRegular credit or alternative simplified credit, calculated on Form 6765
Research done abroadOverseas contractor and externally provided worker payments generally restricted, with a narrow exceptionExcluded: research outside the US or a US territory does not qualify
Tax treatment of the benefitMerged credit taxable as trading income; ERIS payable credit not taxedOffsets US income tax; payroll election up to $500,000 for qualified small businesses
PaperworkAdditional information form before the Company Tax Return; claim notification form for claims before 1 April 2027Form 6765 with the return; Section G detail required for tax years beginning after 2025
Time limitTwo years from the end of the period of account (up to 18 months)Original return, or an amended return with the specific information the IRS requires

What happens if the research is done in the US or by a US subsidiary?

When a UK company pays someone abroad to do its R&D, the UK scheme restricts the claim. GOV.UK guidance says spend on externally provided workers whose earnings are not subject to UK PAYE, and contractor payments for R&D undertaken overseas only, are excluded from qualifying expenditure under both schemes unless the exception in section 1138A of the Corporation Tax Act 2009 applies. That exception needs conditions that are necessary for the research, are not present in the UK, are present where the work is done, and that it would be wholly unreasonable for the company to replicate in the UK. HMRC says cost and availability of workers are disregarded.

For a founder, the practical point is that a US subsidiary engineering team funded by the UK parent is not a simple way to get both reliefs. The UK parent's payment for that work faces the overseas restriction. The US subsidiary's credit has its own test, because the IRS instructions list research funded by another person as excluded, so the funding terms of any inter-company agreement need to be checked before a credit is assumed. The US side also asks about transfer pricing and the entity's employees, which our guide to a Delaware C corporation with a UK founder covers from the founder's side.

Only the company that decides to do the research can claim

For accounting periods beginning on or after 1 April 2024, GOV.UK says only the company that makes the decision that R&D needs to be carried out can claim for the work, and a contractor can claim only if it can show that it made that decision and planned the R&D. Group structures should record who decides, because a UK Ltd and a US subsidiary working on one product can each look like the decision maker on paper.

How is a UK R&D credit treated for US tax?

In general terms, the UK credit and the UK deduction feed into the UK company's profit and loss, and from there into any US computation of that company's income. The merged credit is taxable income in the UK, so it raises UK Corporation Tax and sits in the profit the US owner looks through to when the company is a controlled foreign corporation. ERIS reduces the company's trading losses while paying out a credit. How each item is categorised in the US calculation, and whether a credit is income or a reduction of cost, depends on the facts and on the US rules, so the figures should be built on one set of numbers for both countries.

Section 174 can matter even without a US credit. The IRS describes foreign research and experimental expenditures as amortised over 15 years, so a UK company with large R&D spending may be capitalising costs in a US-style computation that it fully deducts in the UK. That difference can change the tested income that feeds GILTI and the owner's Form 8992, which our GILTI guide for UK company owners walks through. Pay and dividend choices interact with the same numbers, as explained in salary vs dividends for a US citizen with a UK company.

Illustrative example: one startup, two ways to place the work

Illustrative example: all figures are assumed for the arithmetic only and are not a forecast or a promise of any claim. A UK Ltd owned by one US citizen has an accounting period beginning on 1 April 2025. It has £200,000 of qualifying R&D costs, and employs engineers in the UK. It pays Corporation Tax at the 25% main rate when profitable. Currency effects are ignored.

  1. Profit-making UK Ltd, merged scheme. Credit: £200,000 × 20% = £40,000. Notional tax on the credit at 25%: £40,000 × 25% = £10,000. Net benefit: £40,000 − £10,000 = £30,000, or 15% of the qualifying costs. The credit is first set against Corporation Tax and is subject to the PAYE cap.
  2. Loss-making UK Ltd, ERIS. Assume R&D is at least 30% of total spend, the trading loss after the extra deduction is at least £372,000, and the PAYE and National Insurance cap is not binding. Additional deduction: £200,000 × 86% = £172,000. Enhanced expenditure: £200,000 × 186% = £372,000. Payable credit: £372,000 × 14.5% = £53,940, which is 27% of the costs, in return for giving up that amount of loss.
  3. US view of the same UK spend. Section 41 credit for the UK research: nil, because it is research outside the United States. For a US-style computation of the company's income, the same £200,000 is foreign research: £200,000 ÷ 15 years × half a year = about £6,667 deductible in year one, against £200,000 in the UK computation.
  4. The same £200,000 of research done by a US subsidiary in the US. The UK parent's payment to it generally falls under the overseas restriction, and the US subsidiary would test its own Section 41 position, including the funded-research exclusion. Domestic research costs can be deducted under Section 174A. The UK claim could be reduced while the US result depends on the contract terms.

The example shows the shape of the issue, not a ranking. For a UK-based team the UK scheme does the work and the US side is a reporting and computation matter. For a US-based team the position reverses and the UK scheme may add little.

What does a UK claim need: forms, deadlines and records?

The UK mechanics are form-heavy and an invalid form means an invalid claim. Check each against the current GOV.UK pages.

  • Claim notification form. Needed for a first claim, or where the last claim was more than three years before the end of the notification period. It must be submitted within six months of the end of the period of account. HMRC's guidance says it is not required for claims made on or after 1 April 2027.
  • Additional information form. Must be submitted before, or on the same day as and before, the Company Tax Return. If the return goes first, HMRC says the claim will be rejected.
  • Company Tax Return and CT600L. The credit is shown as taxable income for the merged scheme, boxes 656 and 657 record the forms, and CT600L supports a payable credit.
  • Time limit. HMRC's manual says claims can be made, amended or withdrawn up to two years from the end of the period of account where it is not longer than 18 months, with discretion for late claims limited by HMRC's own statement of practice.

As a worked timeline, a company with a 31 March 2026 year end has until 31 March 2028 to make or amend its claim, and the six-month notification period for a first claim ended on 30 September 2026. Check which of these applies before preparing the return, because a missed form can make the claim invalid.

On the US side, keep contemporaneous records of who did the work, where they were located, what uncertainty was being resolved and who paid for it. The IRS requires business component detail in Section G of Form 6765 for tax years beginning after 2025, so a US filer will need project-level records. One set of project notes, timesheets by location and contracts can serve both countries if they are kept to the stricter standard from the start.

How should a founder structure a UK Ltd or US entity around R&D?

  1. Decide where the people work. UK staff on UK PAYE support the UK claim. US-based staff support a US credit. Staff paid through an overseas provider are the problem group for the UK claim.
  2. Decide who owns the decision. The company that decides R&D is needed and plans it is the one that can claim. Write that into board minutes and contracts.
  3. Check connected-company effects. For ERIS, a US affiliate's spending counts in the 30% intensity test, and for the PAYE cap the claimant's own payroll is what counts.
  4. Model both countries together. A UK credit changes UK profit, which changes the US computation, which changes the owner's US tax. See UK vs US entity choice for the wider structure question.
  5. Plan the filings. UK forms before the Company Tax Return, Form 5471 and Form 6765 where relevant with the US return, and a diary of both calendars.

What founders get wrong about R&D credits across the border

  • "My US citizenship gets me the US credit." The Section 41 credit follows where the research is done, not who owns the company.
  • "A US subsidiary can do the work and the UK parent claims it." The UK overseas restrictions on contractor and externally provided worker payments apply to exactly this pattern.
  • "The credit is free money." The merged credit is taxable, the claim can be enquired into, and a claim made without the right forms is invalid.
  • "No US effect, so no US work." The company's R&D spending still feeds the US computation of its income and Form 5471.
  • "Section 174 only hits US companies." Foreign research costs are the part of Section 174 that remains after 2025.

Getting the R&D tax credit US UK position right

US/UK Cross Border Tax — US CPAs and UK tax advisers working as one team, from London, Manchester, New York and San Francisco — looks at the UK claim and the US computation on one set of numbers. If you run a startup with ties to both countries, see our page for founders with an R&D tax credit US UK question, our international tax and business tax return services, or contact us before the spending plan is set. We cannot say a claim will succeed, because both HMRC and the IRS look at the facts of each project.

Frequently asked questions

Can a UK company claim the US R&D tax credit?

Generally not for UK research. The IRS instructions for Form 6765 exclude research conducted outside the United States or a US territory from the Section 41 credit. A UK company is also a foreign corporation for US purposes, so the credit is aimed at a US taxpayer's US research. UK research is looked at under the UK scheme instead.

Can a US citizen who owns a UK company claim UK R&D tax relief?

The claim belongs to the company, not the owner. A UK company that is trading, chargeable to Corporation Tax and carrying out qualifying R&D can claim whoever owns it. The owner's US citizenship does not change the UK conditions, although it adds US reporting such as Form 5471 and can change how the credit is treated in the US computation.

Is the UK R&D credit taxable?

Under the merged scheme, GOV.UK says the credit is taxable because it is classed as trading income. The company shows it as taxable income, and the net benefit is the credit less notional tax at the applicable Corporation Tax rate. Enhanced R&D intensive support for loss-making SMEs works differently, because the payable credit is not liable to tax, but the extra deduction uses up losses.

What is the deadline to claim UK R&D relief?

For a period of account of up to 18 months, a claim can be made or amended up to two years from the end of the period of account. HMRC guidance also requires a claim notification form within six months of the period end for first-time claimants and some others, until claims made on or after 1 April 2027. Check the current guidance for your period.

Does Section 174 still stop US companies deducting R&D costs?

Not for domestic research. Section 174A, added by Public Law 119-21, lets taxpayers deduct domestic research and experimental expenditures in tax years beginning after December 31, 2024, or elect to amortise them over at least 60 months. Foreign research expenditures stay under Section 174 and are amortised over 15 years from the midpoint of the tax year.

Can a small US company use R&D credits against payroll tax?

Yes, if it is a qualified small business. The IRS instructions describe an annual election, capped at $500,000, to apply the research credit against the employer portion of social security tax. The business needs gross receipts under $5 million for the tax year and no gross receipts before the five-tax-year period ending with the current year. The election cannot be made for more than five tax years.

Should a UK startup with a US founder put the research in the UK or the US?

There is no universal answer, because the two incentives reward different places. UK research can support a UK claim, and US research can support a Section 41 credit for a US taxpayer. Hiring, funding, investor and tax-residence facts matter as much as the incentive, so model both countries before choosing.

This article is general information, not personal tax advice. Thresholds, rates and deadlines change; confirm current figures on the official sources above and speak to a qualified US/UK tax adviser about your own circumstances.

Written by the US/UK Cross Border Tax team — US CPAs and UK tax advisers, London · Manchester · New York · San Francisco. About us. Last reviewed: November 17, 2026.

Running R&D from a UK company with US ties?

We review where the research happens, which entity can claim and how the UK relief feeds into the owner's US return, before the spending plan is fixed.

Get a Fee Quote
Contact US/UK Cross Border Tax

Two Tax Systems, One Team

London Headquarters

4 Crown Place
London EC2A 4BT
United Kingdom

Manchester

CORE
Brown St, Manchester M2 1DH
United Kingdom

San Francisco

600 California St
San Francisco, CA 94108
United States

New York

33 Irving Pl
New York, NY 10003
United States

Start a Conversation